Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements."
Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects", "will," "anticipates," "estimates," "believes," "understands" or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Growth Stock Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice.
In compliance with the Securities Act of 1933, Section17(b), Emerging Growth Stock Alert discloses the receipt of twenty five million unrestricted shares of WSCH from a third party for the publication of this report and additional services related to WSCH. Be aware of an inherent conflict of interest resulting from such compensation due to our intent to profit from the sale of these shares. All factual information in this report was gathered from public sources, including but not limited to SEC filings, Company Press Releases, and the company's website at wasatchpharm.com. Emerging Growth Stock Alert believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms.
If you feel that this service is no longer of benefit to you, and you do not want to be notified along with the investors on this list, please click reply and include "Remove" in the subject. NOTE: By removing your email address from the recipients you will no longer receive your FREE company advisory nor the FREE company update in the Future.